Filter
731
Text search:
viral
suppression
Featured
61
203
Language
Document type
478
106
101
12
11
9
8
3
2
1
Countries / Regions
30
29
27
21
20
19
19
15
15
12
12
11
11
9
8
7
7
7
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
270
69
21
9
3
2
2
1
Toolboxes
342
39
21
13
11
10
8
7
5
4
4
3
2
2
1
1
1
Yu et al. BMC Public Health (2018) 18:825 https://doi.org/10.1186/s12889-018-5731-z
Research Article
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0189770 January 2, 2018
HIV i-Base
July 2018
BMC Public Health (2016) 16:766
DOI 10.1186/s12889-016-3455-5
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA
...
Technical Update
HIV Treatment
July 2017
2018 Controlling the HIV Epidemic Summit Geneva, 3-4 May 2018
3 May 2018
Research Article
PLOS Medicine | DOI:10.1371/journal.pmed.1002253 April 4, 2017
Research Article
Hindawi
BioMed Research International
Volume 2018, Article ID 9619684, 10 pages https://doi.org/10.1155/2018/9619684
Guidance
Indicators for monitoring the 2016 Political Declaration on Ending AIDS
UNAIDS Joint United Nations Programme on HIV/AIDS
Accessed Febr. 6, 2020
Developed by the HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission—
A Working Group of the Office of AIDS Research Advisory Council (OARAC)
Accessed: 12.02.2020
Dziva Chikwari et al. Implementation Science (2018) 13:70 https://doi.org/10.1186/s13012-018-0762-5
The COVID-19 pandemic has affected everyone, including key populations at higher risk of HIV. And the gains made against other infectious diseases, including HIV, are at risk of being reversed as a result of disruptions caused by COVID-19. This is the background to a new report published by FHI 360,
...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re
...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
